Virtual Symposia on Antidepressants, Irritable Bowel Syndrome, and Stroke Treatment Now on ASHP Web Site
"This new program uses the best and newest technologies to bring continuing education right to your desktop," said Barbara Hammonds, director of ASHPs Educational Services Division.
"Differentiating and Choosing Between Antidepressant Pharmacotherapies" provides an overview of the pharmacokinetic properties and potential adverse effects, drug interactions, and patient considerations associated with new antidepressants. "Irritable Bowel Syndrome: Therapy for the New Millennium" provides pharmacists with detailed information and current strategies for the treatment of this chronic disease. "Treatment of StrokeY2K" addresses the challenges of treating stroke, concerns over current therapeutic strategies, and the latest information about investigational agents and new therapies.
These programs are funded by an education grant from Glaxo Wellcome Inc., and are part of the Glaxo Wellcome Sunrise Seminar Series, a popular educational symposia conducted in conjunction with the 34th Annual ASHP Midyear Clinical Meeting held in Orlando in December 1999.
ASHP is the 30,000-member national professional association that represents pharmacists who practice in hospitals, health maintenance organizations, long-term care facilities, home care, and other components of health care systems. ASHP, which has a long and distinguished history of medication error
prevention efforts, believes that the mission of pharmacists is to help people make the best use of medicine. Assisting pharmacists in fulfilling this mission is ASHP's primary objective. The Society has extensive publishing and educational programs designed to help members improve their delivery of pharmaceutical care, and it is the national accrediting organization for pharmacy residency and pharmacy technician training programs.